Speaker illustration

Doctor Alexander Assmann

Heinrich Heine University Medical School, Duesseldorf (Germany)

Very low-dose recombinant factor VIIa for optimized treatment of cardiovascular patients at high risk of hemorrhage

Event: ESC CONGRESS 2016

Topic: Thrombosis and coagulation

Session: Antithrombotics in daily clinical practice


ESC 365 is supported by

logo Novo Nordisk